The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Nick S. Macklon,
Richard L. Stouffer,
Linda C. Giudice and
Bart C. J. M. Fauser
Department of Reproductive Medicine and Gynecology (N.S.M., B.C.J.M.F.), University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands; Division of Reproductive Sciences (R.L.S.), Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon 97239-3098; and Department of Obstetrics and Gynecology (L.C.G.), Stanford University School of Medicine, Stanford, California 94305
Correspondence: Address all correspondence and requests for reprints to: N. S. Macklon, Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. E-mail: n.s.macklon{at}umcutrecht.nl
To allow selection of embryos for transfer after in vitro fertilization,ovarian stimulation is usually carried out with exogenous gonadotropins.To compensate for changes induced by stimulation, GnRH analogcotreatment, oral contraceptive pretreatment, late follicularphase human chorionic gonadotropin, and luteal phase progesteronesupplementation are usually added. These approaches render ovarianstimulation complex and costly. The stimulation of multiplefollicular development disrupts the physiology of folliculardevelopment, with consequences for the oocyte, embryo, and endometrium.In recent years, recombinant gonadotropin preparations havebecome available, and novel stimulation protocols with lessdetrimental effects have been developed. In this article, thescientific background to current approaches to ovarian stimulationfor in vitro fertilization is reviewed. After a brief discussionof the relevant aspect of ovarian physiology, the development,application, and consequences of ovarian stimulation strategiesare reviewed in detail.
This article has been cited by other articles:
A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, A. C. Artenisio, G. Stabile, and A. Volpe Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
Hum. Reprod. Update,
March 1, 2010;
16(2):
113 - 130.
[Abstract][Full Text][PDF]
S. Altmae, J.A. Martinez-Conejero, A. Salumets, C. Simon, J.A. Horcajadas, and A. Stavreus-Evers Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility
Mol. Hum. Reprod.,
March 1, 2010;
16(3):
178 - 187.
[Abstract][Full Text][PDF]
M. A. Santos, E. W Kuijk, and N. S Macklon The impact of ovarian stimulation for IVF on the developing embryo
Reproduction,
January 1, 2010;
139(1):
23 - 34.
[Abstract][Full Text][PDF]
M. A. Edson, A. K. Nagaraja, and M. M. Matzuk The Mammalian Ovary from Genesis to Revelation
Endocr. Rev.,
October 1, 2009;
30(6):
624 - 712.
[Abstract][Full Text][PDF]
B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency
Hum. Reprod. Update,
May 1, 2009;
15(3):
309 - 321.
[Abstract][Full Text][PDF]
S. M. Nelson, R. W. Yates, H. Lyall, M. Jamieson, I. Traynor, M. Gaudoin, P. Mitchell, P. Ambrose, and R. Fleming Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Hum. Reprod.,
April 1, 2009;
24(4):
867 - 875.
[Abstract][Full Text][PDF]
P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, E. Kolibianakis, W. Ledger, C. Tomas, and B. C.J.M. Fauser Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment
Hum. Reprod.,
April 1, 2009;
24(4):
764 - 774.
[Abstract][Full Text][PDF]
X. Wu Maternal depletion of NLRP5 blocks early embryogenesis in rhesus macaque monkeys (Macaca mulatta)
Hum. Reprod.,
February 1, 2009;
24(2):
415 - 424.
[Abstract][Full Text][PDF]
M.F.G. Verberg, M.J.C. Eijkemans, N.S. Macklon, E.M.E.W. Heijnen, E.B. Baart, F.P. Hohmann, B.C.J.M. Fauser, and F.J. Broekmans The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis
Hum. Reprod. Update,
January 1, 2009;
15(1):
5 - 12.
[Abstract][Full Text][PDF]
M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser Mild ovarian stimulation for IVF
Hum. Reprod. Update,
January 1, 2009;
15(1):
13 - 29.
[Abstract][Full Text][PDF]
G. F. Weinbauer, M. Niehoff, M. Niehaus, S. Srivastav, A. Fuchs, E. Van Esch, and J. M. Cline Physiology and Endocrinology of the Ovarian Cycle in Macaques
Toxicol Pathol,
December 1, 2008;
36(7_suppl):
7S - 23S.
[Abstract][Full Text][PDF]
J. C. Boxmeer, R. P.M. Steegers-Theunissen, J. Lindemans, M. F. Wildhagen, E. Martini, E. A.P. Steegers, and N. S. Macklon Homocysteine metabolism in the pre-ovulatory follicle during ovarian stimulation
Hum. Reprod.,
November 1, 2008;
23(11):
2570 - 2576.
[Abstract][Full Text][PDF]
M.F.G. Verberg, M.J.C. Eijkemans, E.M.E.W. Heijnen, F.J. Broekmans, C. de Klerk, B.C.J.M. Fauser, and N.S. Macklon Why do couples drop-out from IVF treatment? A prospective cohort study
Hum. Reprod.,
September 1, 2008;
23(9):
2050 - 2055.
[Abstract][Full Text][PDF]
N. S. Macklon, M. H. van der Gaast, A. Hamilton, B. C. J. M. Fauser, and L. C. Giudice The Impact of Ovarian Stimulation With Recombinant FSH in Combination With GnRH Antagonist on the Endometrial Transcriptome in the Window of Implantation
Reproductive Sciences,
April 1, 2008;
15(4):
357 - 365.
[Abstract][PDF]
Y.-L. Lee, Y. Liu, P.-Y. Ng, K.-F. Lee, C.-L. Au, E. H.-Y. Ng, P.-C. Ho, and W. S.-B. Yeung Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-A in peri-implantation endometrium after gonadotrophin stimulation
Hum. Reprod.,
April 1, 2008;
23(4):
894 - 903.
[Abstract][Full Text][PDF]
S. Polinder, E.M.E.W. Heijnen, N.S. Macklon, J.D.F. Habbema, B.J.C.M. Fauser, and M.J.C. Eijkemans Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint
Hum. Reprod.,
February 1, 2008;
23(2):
316 - 323.
[Abstract][Full Text][PDF]
The ESHRE Capri Workshop Group Intracytoplasmic sperm injection (ICSI) in 2006: Evidence and Evolution
Hum. Reprod. Update,
November 1, 2007;
13(6):
515 - 526.
[Abstract][Full Text][PDF]
G. Nargund, B.C.J.M. Fauser, N.S. Macklon, W. Ombelet, K. Nygren, R. Frydman, and for the Rotterdam ISMAAR Consensus Group on Termin The ISMAAR proposal on terminology for ovarian stimulation for IVF
Hum. Reprod.,
November 1, 2007;
22(11):
2801 - 2804.
[Abstract][Full Text][PDF]
K. J. McTavish, M. Jimenez, K. A. Walters, J. Spaliviero, N. P. Groome, A. P. Themmen, J. A. Visser, D. J. Handelsman, and C. M. Allan Rising Follicle-Stimulating Hormone Levels with Age Accelerate Female Reproductive Failure
Endocrinology,
September 1, 2007;
148(9):
4432 - 4439.
[Abstract][Full Text][PDF]
M. W. Szkudlinski Challenges and Opportunities of Trapping Ligands
Mol. Pharmacol.,
August 1, 2007;
72(2):
231 - 234.
[Abstract][Full Text][PDF]
E. B. Baart, E. Martini, M. J. Eijkemans, D. Van Opstal, N. G.M. Beckers, A. Verhoeff, N. S. Macklon, and B. C.J.M. Fauser Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial
Hum. Reprod.,
April 1, 2007;
22(4):
980 - 988.
[Abstract][Full Text][PDF]